Literature DB >> 10972663

Effects of renal denervation on the sodium excretory actions of leptin in hypertensive rats.

D Villarreal1, G Reams, R H Freeman.   

Abstract

BACKGROUND: Previous studies from this laboratory have reported a marked attenuation of the renal responses to pharmacologic doses of synthetic murine leptin infused in the spontaneously hypertensive rat (SHR) model compared with normotensive Sprague-Dawley and lean Zucker rat models.
METHODS: In the present study, the hemodynamic and renal excretory effects of an intravenous bolus administration of pharmacologic doses of synthetic murine leptin were examined in groups of anesthetized SHR with unilateral nephrectomy and renal denervation or sham-denervation of the remaining kidney.
RESULTS: In the SHR with acute renal denervation (N = 8), an intravenous bolus of 1600 microg/kg of leptin produced a significant twofold to fourfold elevation in sodium excretion but did not increase natriuresis in the sham-denervated group (N = 6). Chronic renal denervation of one-week duration (N = 8) was associated with qualitatively and quantitatively similar increases of sodium excretion in response to leptin administration. Mean arterial pressure remained unchanged in all groups after the administration of leptin.
CONCLUSIONS: Collectively, these results are interpreted to suggest that the blunted natriuretic and diuretic responses to leptin observed in the SHR with intact renal nerves may be partially explained by the antinatriuretic effect of an enhanced baseline efferent renal sympathetic activity and/or leptin's stimulation of the sympathetic nervous system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972663     DOI: 10.1046/j.1523-1755.2000.00256.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  The unfolding tale of leptin.

Authors:  H Jeet Singh
Journal:  Malays J Med Sci       Date:  2001-07

Review 2.  Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension.

Authors:  W Chen; S Leo; C Weng; X Yang; Y Wu; X Tang
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

3.  Leptin blockade attenuates sodium excretion in saline-loaded normotensive rats.

Authors:  Daniel Villarreal; Garry Reams; Ronald Freeman; Robert Spear; Inna Tchoukina; Huma Samar
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

Review 4.  Mechanisms of adverse cardiometabolic consequences of obesity.

Authors:  Carlos M Diaz-Melean; Virend K Somers; Juan Pablo Rodriguez-Escudero; Prachi Singh; Ondrej Sochor; Ernesto Manuel Llano; Francisco Lopez-Jimenez
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

5.  Leptin and the Regulation of Renal Sodium Handling and Renal Na-Transporting ATPases: Role in the Pathogenesis of Arterial Hypertension.

Authors:  Jerzy Bełtowski
Journal:  Curr Cardiol Rev       Date:  2010-02

6.  Leptin inhibits the proliferation of vascular smooth muscle cells induced by angiotensin II through nitric oxide-dependent mechanisms.

Authors:  Amaia Rodríguez; Javier Gómez-Ambrosi; Victoria Catalán; Ana Fortuño; Gema Frühbeck
Journal:  Mediators Inflamm       Date:  2010-06-01       Impact factor: 4.711

Review 7.  Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.

Authors:  Sanjeev B Patel; Garry P Reams; Robert M Spear; Ronald H Freeman; Daniel Villarreal
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

8.  The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast.

Authors:  Tsung-Chieh Lin; Tien-Chiang Lee; Shih-Lan Hsu; Chung-Shi Yang
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

9.  Obesity hypertension: the regulatory role of leptin.

Authors:  Shilpa Kshatriya; Kan Liu; Ali Salah; Tamas Szombathy; Ronald H Freeman; Garry P Reams; Robert M Spear; Daniel Villarreal
Journal:  Int J Hypertens       Date:  2011-01-03       Impact factor: 2.420

10.  The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.

Authors:  Omar M Kaisar; David W Johnson; Judith B Prins; Nicole Isbel
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.